Chitneni SK - Search Results

1

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.

Gedeon PC, Schaller TH, Chitneni SK, Choi BD, Kuan CT, Suryadevara CM, Snyder DJ, Schmittling RJ, Szafranski SE, Cui X, Healy PN, Herndon JE 2nd, McLendon RE, Keir ST, Archer GE, Reap EA, Sanchez-Perez L, Bigner DD, Sampson JH. Gedeon PC, et al. Among authors: chitneni sk. Clin Cancer Res. 2018 Aug 1;24(15):3611-3631. doi: 10.1158/1078-0432.CCR-17-0126. Epub 2018 Apr 27. Clin Cancer Res. 2018. PMID: 29703821 Free PMC article.

2

Copper signaling axis as a target for prostate cancer therapeutics.

Safi R, Nelson ER, Chitneni SK, Franz KJ, George DJ, Zalutsky MR, McDonnell DP. Safi R, et al. Among authors: chitneni sk. Cancer Res. 2014 Oct 15;74(20):5819-31. doi: 10.1158/0008-5472.CAN-13-3527. Cancer Res. 2014. PMID: 25320179 Free PMC article.

3

18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.

Chitneni SK, Bida GT, Yuan H, Palmer GM, Hay MP, Melcher T, Wilson WR, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. J Nucl Med. 2013 Aug;54(8):1339-46. doi: 10.2967/jnumed.112.116293. Epub 2013 Jun 5. J Nucl Med. 2013. PMID: 23740105 Free PMC article.

4

Synthesis and evaluation of radiolabeled AGI-5198 analogues as candidate radiotracers for imaging mutant IDH1 expression in tumors.

Chitneni SK, Reitman ZJ, Spicehandler R, Gooden DM, Yan H, Zalutsky MR. Chitneni SK, et al. Bioorg Med Chem Lett. 2018 Feb 15;28(4):694-699. doi: 10.1016/j.bmcl.2018.01.015. Epub 2018 Jan 12. Bioorg Med Chem Lett. 2018. PMID: 29366652 Free PMC article.

5

Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogs.

Chitneni SK, Reitman ZJ, Gooden DM, Yan H, Zalutsky MR. Chitneni SK, et al. Eur J Med Chem. 2016 Aug 25;119:218-30. doi: 10.1016/j.ejmech.2016.04.066. Epub 2016 Apr 28. Eur J Med Chem. 2016. PMID: 27163884 Free PMC article.

6

Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.

Chitneni SK, Bida GT, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. J Nucl Med. 2014 Jul;55(7):1192-7. doi: 10.2967/jnumed.114.137448. Epub 2014 May 22. J Nucl Med. 2014. PMID: 24854792 Free PMC article.

7

Observations on the Effects of Residualization and Dehalogenation on the Utility of N-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab.

Chitneni SK, Koumarianou E, Vaidyanathan G, Zalutsky MR. Chitneni SK, et al. Molecules. 2019 Oct 30;24(21):3907. doi: 10.3390/molecules24213907. Molecules. 2019. PMID: 31671554 Free PMC article.

8

Synthesis and Evaluation of a ¹⁸F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET.

Chitneni SK, Yan H, Zalutsky MR. Chitneni SK, et al. ACS Med Chem Lett. 2018 May 1;9(7):606-611. doi: 10.1021/acsmedchemlett.7b00478. eCollection 2018 Jul 12. ACS Med Chem Lett. 2018. PMID: 30034587 Free PMC article.

9

IDH1 Mutations in Glioma: Considerations for Radiotracer Development.

Chitneni SK. Chitneni SK. SM Radiol J. 2016;2(1):1009. Epub 2016 Mar 26. SM Radiol J. 2016. PMID: 27158682 Free PMC article. No abstract available.

10

Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation.

Zhou Z, Zalutsky MR, Chitneni SK. Zhou Z, et al. Among authors: chitneni sk. Mol Pharm. 2021 Oct 4;18(10):3871-3881. doi: 10.1021/acs.molpharmaceut.1c00531. Epub 2021 Sep 15. Mol Pharm. 2021. PMID: 34523337 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page